Medline dips a day after strong Nasdaq debut

Medline

18/12/2025 10:27

** Shares of medical supply firm Medline MDLN.O down 3.7% at $39.50 premarket a day after strong Nasdaq debut

** Stock surged 41% on Wednesday; having opened at $35 vs $29 IPO price, giving co around $46 bln valuation in the largest U.S. IPO since Rivian's RIVN.O 2021 listing

** MDLN announced selling about 216 mln shares, above its plans to offer 179 mln shares, at upper end of $26-$30 range for deal size of about $6.3 bln

** Co said it plans to use proceeds to repay term loan debt and redeem equity interests from pre-IPO owners, per statement

 (Reporting by Tharuniyaa Lakshmi in Bengaluru)

 ((tharuniyaa@thomsonreuters.com))